Vitabiotics acquired by BAIN CAPITAL

Bain Capital acquires Vitabiotics, the UK's largest vitamin company, in a transaction that marks a significant milestone in the family business's 55-year history. The operation, announced in July 2026, combines the expertise of a global healthcare and consumer investor with an internationally recognized platform of vitamins, minerals, and supplements brands. The UK remains central to Vitabiotics' brand, innovation, and category leadership. The investment will be led by Bain Capital's Asia Private Equity team, bringing local knowledge of Indian and Asian markets where Vitabiotics has already established leading positions. This structure enables Bain Capital to support Vitabiotics' international growth in key markets like MENA, China, and India, while preserving the company's British heritage. Tej Lalvani, group CEO and son of the founder, retains his role and continues leading the business after more than 30 years with the company. Professor Kartar Lalvani, the founder, assumes an honorary role as Chairman Emeritus. This management continuity preserves the scientific vision and values that have defined Vitabiotics, while accelerating international expansion through digital capabilities, e-commerce, international distribution, and new product development.